Molnupiravir, the oral pill for COVID-19, may actually be driving the emergence of new, potentially harmful, variants of the virus, according to a Wellcome Trust-funded study at the pre-print stage.
On Dec. 13, 2022, the World Health Organisation (WHO) announced that Sir Jeremy Farrar, the current director of the Wellcome Trust, would be joining it as its chief scientist.
A leaked Pfizer document appears to confirm the involvement of a current employee in disclosing confidential information to Project Veritas and warns against so-called "anti-science activists."
A senior Pfizer executive expresses concern over possible side effects of the COVID-19 vaccine on women's reproductive health and menstrual cycles in a video published by Project Veritas.
A study published in the journal International Immunopharmacology found that egg yolk antibodies were effective in neutralizing the SARS-CoV-2 virus with a 75.86% success rate and could potentially be used in spray formulations to prevent the virus from spreading through the respiratory, oral, and digestive tracts.